BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18843197)

  • 1. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.
    Bagnyukova TV; Tryndyak VP; Muskhelishvili L; Ross SA; Beland FA; Pogribny IP
    Cell Cycle; 2008 Oct; 7(20):3202-10. PubMed ID: 18843197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 3. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
    Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
    Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma.
    Chu PY; Yeh CM; Hsu NC; Chang YS; Chang JG; Yeh KT
    Swiss Med Wkly; 2010; 140():w13065. PubMed ID: 20648401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma.
    Gui Y; Yeganeh M; Donates YC; Tobelaim WS; Chababi W; Mayhue M; Yoshimura A; Ramanathan S; Saucier C; Ilangumaran S
    Oncogene; 2015 Nov; 34(46):5718-28. PubMed ID: 25728680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma.
    Liu L; Li W; Wei X; Cui Q; Lou W; Wang G; Hu X; Qian C
    Gene Ther; 2013 Jan; 20(1):84-92. PubMed ID: 22318090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
    Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
    Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
    Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
    Jang JY; Jeon YK; Lee CE; Kim CW
    Int J Oncol; 2013 Feb; 42(2):574-82. PubMed ID: 23242177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.
    Zhang X; Wang J; Cheng J; Ding S; Li M; Sun S; Zhang L; Liu S; Chen X; Zhuang H; Lu F
    J Viral Hepat; 2014 Apr; 21(4):264-71. PubMed ID: 23941364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of MET receptor signaling by SOCS1 and its implications for hepatocellular carcinoma.
    Gui Y; Yeganeh M; Cepero-Donates Y; Ramanathan S; Saucier C; Ilangumaran S
    Curr Pharm Des; 2014; 20(17):2922-33. PubMed ID: 23944359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients.
    Saelee P; Chuensumran U; Wongkham S; Chariyalertsak S; Tiwawech D; Petmitr S
    Asian Pac J Cancer Prev; 2012; 13(7):3489-93. PubMed ID: 22994783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.
    Wu WY; Kim H; Zhang CL; Meng XL; Wu ZS
    J Invest Surg; 2014 Aug; 27(4):197-204. PubMed ID: 24476004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model.
    Attia YM; Tawfiq RA; Gibriel AA; Ali AA; Kassem DH; Hammam OA; Elmazar MM
    Biochem Pharmacol; 2021 Apr; 186():114497. PubMed ID: 33675775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis.
    Lee JI; Wright JH; Johnson MM; Bauer RL; Sorg K; Yuen S; Hayes BJ; Nguyen L; Riehle KJ; Campbell JS
    Am J Physiol Cell Physiol; 2016 Mar; 310(6):C436-45. PubMed ID: 26632601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of Steamed and Freeze-Dried Mature Silkworm Larval Powder Prevents Hepatic Fibrosis and Hepatocellular Carcinogenesis by Blocking TGF-β/STAT3 Signaling Cascades in Rats.
    Lee DY; Yun SM; Song MY; Ji SD; Son JG; Kim EH
    Cells; 2020 Feb; 9(3):. PubMed ID: 32121064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
    Lee TL; Yeh J; Van Waes C; Chen Z
    Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
    Martínez-Chantar ML; Vázquez-Chantada M; Ariz U; Martínez N; Varela M; Luka Z; Capdevila A; Rodríguez J; Aransay AM; Matthiesen R; Yang H; Calvisi DF; Esteller M; Fraga M; Lu SC; Wagner C; Mato JM
    Hepatology; 2008 Apr; 47(4):1191-9. PubMed ID: 18318442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma.
    Bock CT; Toan NL; Koeberlein B; Song le H; Chin R; Zentgraf H; Kandolf R; Torresi J
    Intervirology; 2008; 51(6):432-43. PubMed ID: 19321929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.